Associate ProfessorOchsner Clinic Foundation, United States
Safety, Efficacy, and Outcomes of 90-Yttrium Radioembolization in Combination with Immune Checkpoint Inhibitors as a Definitive First-Line Treatment Approach in Non-Surgical Hepatocellular Carcinoma
Monday, March 31, 20254:03 PM – 4:12 PM CT
Utilization of Non-invasive Fibrosis Indices to Stratify MASH-HCC Progression Risk Following Liver Directed Therapy in BCLC A/B Patients
Monday, March 31, 20253:36 PM – 3:54 PM CT
Persistent AFP Positivity After Liver-Directed Therapy Helps Predict Residual Disease Despite Imaging Response in Early-Stage Hepatocellular Carcinoma
Monday, March 31, 20253:45 PM – 3:54 PM CT
.jpg)